Tamar Lasky

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Coronavirus Disease

Quality Control

Top Venues

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Alecia Clary, Nancy D Lin, Tamar Lasky, Matthew W Reynolds, Anand Chokkalingam, Carla Rodriguez-Watson
Considerations for Defining Medication Exposure When Analyzing Real-World Data. Pharmacoepidemiology and drug safety (2023)
Elizabeth M Garry, Andrew R Weckstein, Kenneth Quinto, Marie C Bradley, Tamar Lasky, Aloka G Chakravarty, Sandy Leonard, Sarah E Vititoe, Imaani J Easthausen, Jeremy A Rassen, Nicolle M Gatto
Categorization of COVID-19 severity to determine mortality risk. Pharmacoepidemiology and drug safety 31 (7) (2022)
Tamar Lasky
Ascertaining vaccine exposure at the brand level using real-world data. Pharmacoepidemiology and drug safety 28 (6) (2019)